Crossmark

Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinoma

Crossref DOI link: https://doi.org/10.1186/s40425-019-0630-0

Published Online: 2019-06-20

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Muhitch, Jason B.

Hoffend, Nicholas C.

Azabdaftari, Gissou

Miller, Austin

Bshara, Wiam

Morrison, Carl D.

Schwaab, Thomas

Abrams, Scott I. https://orcid.org/0000-0002-8742-4708
Funding

Funding for this research was provided by:

National Cancer Institute (R01CA172105)
License Information

Text and Data Mining valid from 2019-06-20
More Information

Article History

Received: 11 February 2019

Accepted: 4 June 2019

First Online: 20 June 2019

Ethics approval and consent to participate

: Patient samples were obtained with informed consent at Roswell Park Comprehensive Cancer Center. Studies were performed under Roswell Park Comprehensive Cancer Center Institutional Review Board approved protocols.

: (not applicable)

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below